GeneChem is a manager of focused venture capital funds. Since 1997, we have been involved in the launching of companies and in the management of their growth and liquidity events.

GeneChem has been part of investment syndicates which included a wide breadth of marquee international investors as well as smaller local players. The team has knowledge and expertise in various fields of science including biochemistry, chemistry, immunology, oncology, virology, bacteriology, analgesia, ophthalmology and human genetics.

We have invested at the very early stages of start-ups, where hands-on management is required, and also at the later stages such as mezzanine rounds and private placements in public entities. The team's experience is broad and deep-reaching within the biotech investment sector.

1 Westmount Square, Suite 800
Montreal, Quebec
H3Z 2P9

T 514-849-7696
F 514-849-5191

Inès Holzbaur, PhD General Partner

Dr. Holzbaur joined GeneChem in 1999. In 2002, she was promoted to vice president in the context of the closing of the Technologies Fund. In 2006, with the raising of the AgeChem Fund, she became General Partner. Dr. Holzbaur currently co-manages the latest Fund, AmorChem.

She has held several positions as board member of GeneChem portfolio companies in Canada, the US and Europe. Most notably, she was a member of the board of BioVex inc. and Argos Therapeutics inc. She obtained her PhD in chemistry, studying the stereospecificity of the biosynthesis of erythromycin at Cambridge University and before joining GeneChem, was a consultant in the Department of Food Science of McGill University. Her work has been published in Chemistry and Biology, the Journal of the American Chemical Society, Biochemistry and a review of infra-red spectroscopy.

T 514-849-7454
F 514-849-5191



HomeAbout UsGeneChem TechGeneChem TheraAgeChemAmorChemNuChemOur TeamContact UsFrançais

© 2024 GeneChem. All rights reserved. Developed by Grafika Designs a Montreal Web Design company.